These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7488122)

  • 1. Suppression of cyclin D1 but not cdk4 or cyclin A with induction of melanoma terminal differentiation.
    Strasberg Rieber M; Rieber M
    Biochem Biophys Res Commun; 1995 Nov; 216(1):422-7. PubMed ID: 7488122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation.
    Rieber M; Rieber MS
    Cell Growth Differ; 1994 Dec; 5(12):1339-46. PubMed ID: 7696182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human breast carcinoma cells by prostaglandin A2.
    Gorospe M; Liu Y; Xu Q; Chrest FJ; Holbrook NJ
    Mol Cell Biol; 1996 Mar; 16(3):762-70. PubMed ID: 8622677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control.
    Dolznig H; Bartunek P; Nasmyth K; Müllner EW; Beug H
    Cell Growth Differ; 1995 Nov; 6(11):1341-52. PubMed ID: 8562472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cyclin-dependent kinase 4 during adipogenesis involves switching of cyclin D subunits and concurrent binding of p18INK4c and p27Kip1.
    Phelps DE; Xiong Y
    Cell Growth Differ; 1998 Aug; 9(8):595-610. PubMed ID: 9716177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
    Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
    Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse mammary hyperplasias and neoplasias exhibit different patterns of cyclins D1 and D2 binding to cdk4.
    Said TK; Luo L; Medina D
    Carcinogenesis; 1995 Oct; 16(10):2507-13. PubMed ID: 7586159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inducible expression of cyclin D1 in T-47D human breast cancer cells is sufficient for Cdk2 activation and pRB hyperphosphorylation.
    Musgrove EA; Sarcevic B; Sutherland RL
    J Cell Biochem; 1996 Mar; 60(3):363-78. PubMed ID: 8867812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK4/cyclin D1/PCNA complexes during staurosporine-induced G1 arrest and G0 arrest of human fibroblasts.
    Gadbois DM; Peterson S; Bradbury EM; Lehnert BE
    Exp Cell Res; 1995 Sep; 220(1):220-5. PubMed ID: 7664838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of the P27KIP1 protein in human esophageal cancer cell lines that over-express cyclin D1.
    Doki Y; Imoto M; Han EK; Sgambato A; Weinstein IB
    Carcinogenesis; 1997 Jun; 18(6):1139-48. PubMed ID: 9214595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas.
    Masciullo V; Scambia G; Marone M; Giannitelli C; Ferrandina G; Bellacosa A; Benedetti Panici P; Mancuso S
    Int J Cancer; 1997 Aug; 74(4):390-5. PubMed ID: 9291427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin D1 expression is a major target of the cAMP-induced inhibition of cell cycle entry in fibroblasts.
    L'Allemain G; Lavoie JN; Rivard N; Baldin V; Pouyssegur J
    Oncogene; 1997 Apr; 14(16):1981-90. PubMed ID: 9150365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated mis-sense and deletion mutations impair p16INK4 CDK inhibitory activity.
    Lilischkis R; Sarcevic B; Kennedy C; Warlters A; Sutherland RL
    Int J Cancer; 1996 Apr; 66(2):249-54. PubMed ID: 8603820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo.
    Fu YM; Yu ZX; Ferrans VJ; Meadows GG
    Nutr Cancer; 1997; 29(2):104-13. PubMed ID: 9427972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations associated with familial melanoma impair p16INK4 function.
    Ranade K; Hussussian CJ; Sikorski RS; Varmus HE; Goldstein AM; Tucker MA; Serrano M; Hannon GJ; Beach D; Dracopoli NC
    Nat Genet; 1995 May; 10(1):114-6. PubMed ID: 7647780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin E, a redundant cyclin in breast cancer.
    Gray-Bablin J; Zalvide J; Fox MP; Knickerbocker CJ; DeCaprio JA; Keyomarsi K
    Proc Natl Acad Sci U S A; 1996 Dec; 93(26):15215-20. PubMed ID: 8986790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell cycle regulatory proteins in anti-immunoglobulin-stimulated mature B lymphocytes.
    Solvason N; Wu WW; Kabra N; Wu X; Lees E; Howard MC
    J Exp Med; 1996 Aug; 184(2):407-17. PubMed ID: 8760794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
    Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
    Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.